Si-Bone (SIBN) Receivables - Other (2021 - 2022)
Si-Bone's (SIBN) quarterly Receivables - Other came in at $200000.0 in Q4 2022, down 33.33% year-on-year from $300000.0 in Q4 2021, and down 33.33% quarter-over-quarter from $300000.0 in Q4 2021.
Si-Bone (SIBN) Receivables - Other (2021 - 2022) Analysis & Trends
Si-Bone's Receivables - Other history runs 2 years deep, the most recent figure standing at $200000.0 for Q4 2022.
- On a quarterly basis, Receivables - Other fell 33.33% year-over-year to $200000.0 in Q4 2022; TTM through Dec 2022 was $200000.0, a 33.33% decrease from a year earlier, with the FY2022 full-year figure at $200000.0, down 33.33% from the prior year.
- Receivables - Other fell to $200000.0 in Q4 2022 per SIBN's latest filing, from $300000.0 in the prior quarter.
- Across five years, Receivables - Other topped out at $300000.0 in Q4 2021 and bottomed at $200000.0 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Si-Bone | 724.02 Mn | 579.33 Mn | 41.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 200,000.00 |
| Dec 31, 2022 | 200,000.00 |
| Dec 31, 2021 | 300,000.00 |
| Dec 31, 2021 | 300,000.00 |